SSH2
Basic information
Region (hg38): 17:29625938-29930276
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SSH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 62 | 66 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 62 | 2 | 4 |
Variants in SSH2
This is a list of pathogenic ClinVar variants found in the SSH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-29630850-A-G | Benign (Mar 29, 2018) | |||
17-29630876-T-C | not specified | Uncertain significance (Jul 14, 2023) | ||
17-29630936-G-T | not specified | Uncertain significance (Aug 11, 2024) | ||
17-29630977-C-T | not specified | Uncertain significance (Aug 01, 2024) | ||
17-29630993-C-T | not specified | Likely benign (Apr 19, 2023) | ||
17-29631038-G-C | not specified | Uncertain significance (Mar 28, 2024) | ||
17-29631061-C-T | not specified | Uncertain significance (May 03, 2023) | ||
17-29631065-A-G | not specified | Uncertain significance (Oct 20, 2024) | ||
17-29631179-C-T | Benign (Mar 29, 2018) | |||
17-29631201-G-T | not specified | Uncertain significance (Sep 30, 2024) | ||
17-29631203-C-T | not specified | Uncertain significance (Dec 03, 2024) | ||
17-29631212-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
17-29631252-T-A | not specified | Uncertain significance (Jun 29, 2022) | ||
17-29631319-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
17-29631332-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
17-29631346-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
17-29631347-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
17-29631398-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
17-29631410-C-A | not specified | Uncertain significance (Jul 12, 2023) | ||
17-29631428-C-T | not specified | Likely benign (Nov 21, 2022) | ||
17-29631488-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
17-29631544-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
17-29631613-G-C | not specified | Uncertain significance (Oct 10, 2023) | ||
17-29631673-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
17-29631695-G-C | not specified | Uncertain significance (Aug 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SSH2 | protein_coding | protein_coding | ENST00000269033 | 15 | 304339 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00316 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.95 | 612 | 764 | 0.801 | 0.0000397 | 9366 |
Missense in Polyphen | 135 | 286.86 | 0.47062 | 3397 | ||
Synonymous | 0.935 | 269 | 289 | 0.930 | 0.0000149 | 2779 |
Loss of Function | 6.05 | 10 | 61.0 | 0.164 | 0.00000352 | 716 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000268 | 0.000268 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000528 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein. {ECO:0000269|PubMed:11832213}.;
- Pathway
- Regulation of actin cytoskeleton - Homo sapiens (human);Axon guidance - Homo sapiens (human);Regulation of Actin Cytoskeleton
(Consensus)
Recessive Scores
- pRec
- 0.0959
Intolerance Scores
- loftool
- 0.379
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 45.68
Haploinsufficiency Scores
- pHI
- 0.532
- hipred
- Y
- hipred_score
- 0.558
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.748
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ssh2
- Phenotype
Gene ontology
- Biological process
- protein dephosphorylation;regulation of actin polymerization or depolymerization;regulation of lamellipodium assembly;actin cytoskeleton organization;peptidyl-tyrosine dephosphorylation;regulation of axonogenesis
- Cellular component
- extracellular space;cytoplasm;cytoskeleton
- Molecular function
- actin binding;phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein tyrosine/serine/threonine phosphatase activity